Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum - Specialists Track (RECORDING)

Monday, July 18, 2022, 12:00 AM - Thursday, July 17, 2025, 11:59 PM, On Demand

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Specialists held on Monday, June 27, 2022. The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session is targeted towards medical oncologists, urologists and radiation oncologists. Hear from experts: Ali Khakhi, MD, Andrei Iagaru, MD, Sumit Shah, MD and Sandy Srinivas, MD. Topics will include: germline and somatic testing, risk stratification for localized prostate cancer and answer questions on when to do prostatectomy vs radiation.

Release Date: July 18, 2022
Expiration Date: July 17, 2025
Estimated Time to Complete: 1.5 hours
Registration Fee: FREE
*Originally recorded on June 27, 2022 

AMA PRA Category 1 Credits™ (1.50 hours), ANCC Contact Hours (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Identify prostate cancer patients who should be offered genetic testing.
2. Recognize the difference between germline and somatic genetic testing and main categories to test each and their strengths and limitations.
3. Describe the capabilities of PSMA-PET imaging for prostate cancer.
4. Discuss PSMA targeted PET interpretation.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this enduring activity for a maximum of 1.5 ANCC contact hours.  

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References
Click HERE to view the full list of references.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.